Search
Citations & References (13)
Invitrogen™
BrainStain™ Imaging Kit
The BrainStain™ Imaging Kit enables three-color combinatorial labeling of myelin, neurons, and nuclei in brain cryosections in a single 20-minuteRead more
| Catalog Number | Quantity |
|---|---|
| B34650 | 1 kit |
Catalog number B34650
Price (TWD)
17,640.00
Online offer
Ends: 31-Dec-2025
25,200.00Save 7,560.00 (30%)
Each
Quantity:
1 kit
Price (TWD)
17,640.00
Online offer
Ends: 31-Dec-2025
25,200.00Save 7,560.00 (30%)
Each
The BrainStain™ Imaging Kit enables three-color combinatorial labeling of myelin, neurons, and nuclei in brain cryosections in a single 20-minute staining step. The kit contains novel stains that can be used together in one staining solution or separately and replaces traditional methods that can take one to three days. Standard histochemical methods, such as immunohistochemistry are compatible with these stains.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
ColorGreen, Red, Blue
Detection MethodFluorescence
For Use With (Equipment)Fluorescence Microscope
Label or DyeNeuroTrace™ 530⁄615, DAPI, FluoroMyelin™ Green
Product TypeImaging Kit
Quantity1 kit
Shipping ConditionRoom Temperature
Sub Cellular LocalizationNucleus, Myelin, Nissl Bodies
Product LineBrainStain
Unit SizeEach
Contents & Storage
Store in freezer (-5 to -30°C) and protect from light.
Frequently asked questions (FAQs)
What dyes are included in the BrainStain Imaging Kit?
I want to stain brain cryosections. Do you have any kits for this purpose?
Citations & References (13)
Citations & References
Abstract
Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a ß-cyclodextrin.
Journal:Hum Mol Genet
PubMed ID:22869680
'Niemann-Pick type C (NPC) disease, an autosomal recessive disorder caused primarily by loss-of-function mutations in NPC1 gene, is characterized neuropathologically by intracellular cholesterol accumulation, gliosis and neuronal loss in selected brain regions. Recent studies have shown that NPC disease exhibits intriguing parallels with Alzheimer''s disease (AD), including the presence of
The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory.
Journal:J Neurosci
PubMed ID:19494159
'The central nucleus of the amygdala (CeA) has been traditionally viewed in fear conditioning to serve as an output neural center that transfers conditioned information formed in the basolateral amygdala to brain structures that generate emotional responses. Recent studies suggest that the CeA may also be involved in fear memory
Srgap3?/? mice present a neurodevelopmental disorder with schizophrenia-related intermediate phenotypes.
Journal:FASEB J
PubMed ID:22820399
Mutations in the SRGAP3 gene residing on chromosome 3p25 have previously been associated with intellectual disability. Genome-wide association studies have also revealed SRGAP3, together with genes from the same cellular network, as risk genes for schizophrenia. SRGAP3 regulates cytoskeletal dynamics through the RHO protein RAC1. RHO proteins are known to
Dynamic early clusters of nodal proteins contribute to node of Ranvier assembly during myelination of peripheral neurons.
Journal:Elife
PubMed ID:34240706
A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition.
Journal:Neurotherapeutics
PubMed ID:33118131